Advance preclinical research with Virscio at SOT ToxExpo 2025
Visit us at Booth #1261 to engage with our team of experts and explore groundbreaking advancements in toxicology.
Virscio is excited to attend the 2025 Society of Toxicology (SOT) ToxExpo from March 16–20 in Orlando, FL! As a leader in GLP and non-GLP safety toxicology, IND-enabling studies, and preclinical research, we are proud to showcase our latest scientific advancements.
At Booth #1261, our team will be available to discuss how our FDA-accepted African Green Monkey (AGM) model is helping drug developers optimize preclinical safety assessments. In addition to exhibiting, we will be presenting 11 cutting-edge scientific posters covering key areas such as safety toxicology, gene therapy, ophthalmology, and CNS pharmacology.
We look forward to seeing you in Orlando and sharing our latest research with the scientific community!
Posters and Presentations
Don’t miss these Virscio Scientific Posters at SOT ToxExpo 2025
We are proud to present 11 scientific posters that highlight our latest research and advancements in preclinical safety toxicology. Each of these posters provides valuable insights into critical aspects of drug development, from IND-enabling studies to advanced imaging techniques.
Reproducibility of Left & Right Heart Chamber Echocardiographic Measures in the Healthy African Green Monkey
Date & Time: Wed., Mar. 19 at 1:45 p.m.
Location: Poster Board C185
This study demonstrates how non-invasive echocardiographic imaging in African Green Monkeys (AGMs) enhances preclinical cardiovascular safety assessments. It allows real-time monitoring of cardiac function, providing an alternative to traditional post-mortem evaluations.
A 4-Week Repeat-Dose GLP Toxicity Study Following Weekly Intravenous Administration in AGMs
Date & Time: Monday, Nov. 17 from 9:15 a.m. to 11:45 a..m.
Poster Board Number: H409
This poster highlights the use of AGMs in regulatory-compliant GLP safety studies. It emphasizes the benefits of manual restraint techniques for diagnostic procedures, ensuring both high-quality data and animal welfare.
Evaluation of Percutaneous Lumbar Intrathecal Bolus Dosing in Juvenile & Adult AGMs
Date & Time: Monday, Mar. 17 from 9:15 a.m. to 11:45 a.m.
Poster Board Number: N670
This research introduces a non-invasive alternative for CNS drug delivery in AGMs, avoiding catheter implantation. The precise lumbar injection method ensures efficient delivery of therapeutics like antisense oligonucleotides
Optical Coherence Tomography to Monitor Retinal Integrity in Ophthalmic Drug Assessments
Date & Time: Monday, Mar. 17 from 9:15 a.m. to 11:45 a.m.
Poster Board Number: H408
This study demonstrates the value of optical coherence tomography (OCT) in non-invasive monitoring of retinal layers. The method provides high-resolution data for evaluating the safety of ophthalmic drugs in AGMs.Characterization of an African Green Primate Model for Geographic Atrophy Induced by Subretinal Sodium Iodate
Date & Time: Tuesday, Mar. 18 from 1:45 p.m. to 4:15 p.m.
Poster Board Number: N674
This poster presents a novel AGM model for geographic atrophy, induced by subretinal sodium iodate administration. The model addresses translational gaps in AMD research, aiding advancements in ophthalmic drug development.Characterization of the African Green Monkey Fecal Microbiota: Pilot Data & Future Directions
Date & Time: Monday, Mar. 17 from 1:45 p.m. to 4:15 p.m.
Poster Board Number: A110
s research highlights the gut microbiota's role in influencing drug metabolism and systemic health. Pilot data lays the groundwork for exploring microbiota-related impacts on pharmacology and toxicology in AGMs.Case Study: Maxillary Ameloblastoma in an African Green Monkey
Date & Time: Monday, Mar. 17 from 9:15 a.m. to 11:45 a.m.
Poster Board Number: H421
This rare case study describes a maxillary ameloblastoma in an AGM, expanding understanding of background pathology. The findings are critical for distinguishing natural variation from treatment-related effects in preclinical research.3Rs Considerations for Clinical Pathology Evaluations Using AGMs
Date & Time: Monday, Mar. 17 from 1:45 p.m. to 4:15 p.m.
Poster Board Number: A111
This poster explores sedation-free methods for clinical pathology in AGMs, aligning with the principles of Replacement, Reduction, and Refinement (3Rs). These techniques improve animal welfare while maintaining data integrity.Preclinical Safety Assessment of AAV Gene Therapy: Precision IM Administration in AGMs
Date & Time: Monday, Mar. 17 from 9:15 a.m. to 11:45 a.m.
Poster Board Number: H404
This research advances AAV gene therapy with precision intramuscular dosing in AGMs. It highlights improved biodistribution and efficacy, supporting successful clinical translation of novel therapies.A Single-Dose Antisense Oligonucleotide Study for Complement Activation in AGMs
Date & Time: Wed., Mar. 19 from 1:45 p.m. to 4:15 p.m.
Poster Board Number: J471
This study evaluates complement activation risks following systemic ASO delivery in AGMs. It provides critical data for ensuring regulatory compliance in gene therapy safety assessments.3/4Rs: Animal Welfare & Scientific Quality in NHP Safety Assessments
Date & Time: Monday, Mar. 17 from 1:45 p.m. to 4:15 p.m.
Poster Board Number: A112
This poster discusses how ethical research practices with AGMs improve scientific quality while supporting sustainable preclinical studies. The research highlights advancements in animal welfare and safety assessments.Meet with us during the 2025 SOT ToxExpol
Discover how Virscio can meet your toxicology and preclinical research needs!
If you're attending SOT ToxExpo 2025, we invite you to visit our booth and explore how Virscio’s preclinical safety toxicology capabilities can support your drug development programs. Our team is eager to discuss how our expertise in GLP toxicology, molecular biology, histopathology, and advanced imaging can help accelerate your preclinical pipeline.
To schedule a meeting with our team, please fill out the online booking form below or contact us directly. We look forward to the opportunity to connect with you and discuss how we can contribute to your success.